Ratings by Citizens (Reni J. Benjamin)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/15/2026 | Kura Oncology | KURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/4/2026 | Kura Oncology | KURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/2/2026 | Incyte | INCY | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 6/1/2026 | Iovanace Biotherapeutics | IOVA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/28/2026 | Kura Oncology | KURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/13/2026 | Kura Oncology | KURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/2/2026 | Incyte | INCY | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 3/6/2026 | Kura Oncology | KURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/25/2026 | Iovanace Biotherapeutics | IOVA | Upgrade | Market Outperform (Market Perform) |
2.89 (4.33) |
49.83% | Details | |
| 2/2/2026 | Kura Oncology | KURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 12/9/2025 | Kura Oncology | KURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 12/9/2025 | Incyte | INCY | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 12/5/2025 | Kura Oncology | KURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/27/2025 | Kura Oncology | KURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/20/2025 | Kura Oncology | KURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/30/2025 | Kura Oncology | KURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/18/2025 | Incyte | INCY | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 9/17/2025 | Kura Oncology | KURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/11/2025 | Kura Oncology | KURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/15/2025 | Iovanace Biotherapeutics | IOVA | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 6/13/2025 | Kura Oncology | KURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/4/2025 | Kura Oncology | KURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/3/2025 | Iovanace Biotherapeutics | IOVA | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 5/9/2025 | Iovanace Biotherapeutics | IOVA | Downgrade | Market Perform (Market Outperform) |
3.13 (2.89) |
-7.67% | Details | |
| 4/29/2025 | Kura Oncology | KURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/9/2025 | Kura Oncology | KURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/11/2025 | Incyte | INCY | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 8/19/2024 | Incyte | INCY | Maintain | Market Perform (N/A) |
|
Details | ||
| 6/20/2024 | Iovanace Biotherapeutics | IOVA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/20/2024 | Iovanace Biotherapeutics | IOVA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/14/2024 | Incyte | INCY | Downgrade | Market Perform (Market Outperform) |
57.84 (108.47) |
87.53% | Details | |
| 1/31/2024 | Kura Oncology | KURA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/11/2023 | CTI BioPharma | CTIC | Downgrade | Market Perform (Market Outperform) |
4.82 (9.09) |
88.59% | Details | |
| 5/4/2023 | Incyte | INCY | Maintain | Market Outperform (N/A) |
|
Details | ||
| 4/26/2023 | Spectrum Pharmaceuticals | SPPI | Downgrade | Market Perform (Market Outperform) |
0.69 (1.03) |
49.28% | Details | |
| 11/21/2022 | Iovanace Biotherapeutics | IOVA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/9/2022 | CTI BioPharma | CTIC | Maintain | Market Outperform (N/A) |
|
Details | ||
| 7/21/2022 | Incyte | INCY | Maintain | Market Outperform (N/A) |
|
Details | ||
| 4/19/2022 | CTI BioPharma | CTIC | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/2/2022 | CTI BioPharma | CTIC | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/28/2022 | Kura Oncology | KURA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/28/2022 | Iovanace Biotherapeutics | IOVA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/29/2021 | Kura Oncology | KURA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/4/2021 | Incyte | INCY | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/25/2021 | ERYTECH Pharma SA. | ERYP | Downgrade | Market Perform (Market Outperform) |
5.48 (0.78) |
-85.77% | Details | |
| 8/6/2021 | Spectrum Pharmaceuticals | SPPI | Maintain | Market Outperform (N/A) |
|
Details | ||
| 6/10/2021 | Iovanace Biotherapeutics | IOVA | Upgrade | Market Outperform (Market Perform) |
20.59 (4.33) |
-78.97% | Details | |
| 5/19/2021 | Iovanace Biotherapeutics | IOVA | Downgrade | Market Perform (Market Outperform) |
26.97 (4.33) |
-83.95% | Details | |
| 11/6/2020 | Kura Oncology | KURA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/26/2020 | Kura Oncology | KURA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/30/2020 | CTI BioPharma | CTIC | Maintain | Market Outperform (N/A) |
|
Details | ||
| 7/23/2020 | Incyte | INCY | Maintain | Market Outperform (N/A) |
|
Details | ||
| 7/13/2020 | NextCure Inc. | NXTC | Downgrade | Market Perform (Market Outperform) |
17.88 (1.84) |
-89.71% | Details |
